share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma

福泰製藥 | 4：持股變動聲明-高管 Kewalramani Reshma
美股sec公告 ·  05/30 04:14
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals CEO & President, Kewalramani Reshma, completed a stock transaction on 05/24/2024 involving the sale of 1,565 shares of common stock at a price of $457.00 per share. The transaction resulted in a total market value of $715,205. Prior to this sale, Reshma exercised options to acquire the same number of shares at $187.53 per share. Following these transactions, Reshma's direct holdings in Vertex Pharmaceuticals amount to 121,374 shares. The sale took place under the transaction code 'S', indicating an open market or private sale, while the acquisition was coded 'M', signifying the exercise or conversion of derivative security.
Vertex Pharmaceuticals CEO & President, Kewalramani Reshma, completed a stock transaction on 05/24/2024 involving the sale of 1,565 shares of common stock at a price of $457.00 per share. The transaction resulted in a total market value of $715,205. Prior to this sale, Reshma exercised options to acquire the same number of shares at $187.53 per share. Following these transactions, Reshma's direct holdings in Vertex Pharmaceuticals amount to 121,374 shares. The sale took place under the transaction code 'S', indicating an open market or private sale, while the acquisition was coded 'M', signifying the exercise or conversion of derivative security.
Vertex Pharmaceuticals首席執行官兼總裁Kewalramani Reshma於2024年5月24日完成了一項股票交易，涉及以每股457.00美元的價格出售1,565股普通股。該交易的總市值爲715,205美元。在此次出售之前，Reshma行使了期權，以每股187.53美元的價格收購了相同數量的股票。這些交易之後，瑞什瑪在Vertex Pharmicals的直接持股量爲121,374股。此次出售以交易代碼 “S” 進行，表示公開市場或私下出售，而收購的代碼爲 “M”，表示行使或轉換衍生證券。
Vertex Pharmaceuticals首席執行官兼總裁Kewalramani Reshma於2024年5月24日完成了一項股票交易，涉及以每股457.00美元的價格出售1,565股普通股。該交易的總市值爲715,205美元。在此次出售之前，Reshma行使了期權，以每股187.53美元的價格收購了相同數量的股票。這些交易之後，瑞什瑪在Vertex Pharmicals的直接持股量爲121,374股。此次出售以交易代碼 “S” 進行，表示公開市場或私下出售，而收購的代碼爲 “M”，表示行使或轉換衍生證券。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。